5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
    7.
    发明授权
    5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication 有权
    5-或6-取代的苯并咪唑衍生物作为呼吸道合胞病毒复制的抑制剂

    公开(公告)号:US08278455B2

    公开(公告)日:2012-10-02

    申请号:US12253450

    申请日:2008-10-17

    IPC分类号: A61K31/4439 C07D401/06

    摘要: The present invention concerns 5- or 6-substituted-benzimidazole derivatives having inhibitory activity on the replication of the respiratory syncytial virus and having the formula a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein Q is Ar2, R6, pyrrolidinyl substituted with R6, piperidinyl substituted with R6 or homopiperidinyl substituted with R6, G is a direct bond or optionally substituted C1-10alkanediyl; R1 is Ar1 or a monocyclic or bicyclic heterocycle; one of R2a and R2b is cyanoC1-6alkyl, cyanoC2-6alkenyl, Ar3C1-6alkyl, Het1C1-6alkyl, N(R8aR8b)C1-6alkyl, Ar3C2-6alkenyl, Het1C2-6alkenyl, Ar3aminoC1-6alkyl, Het1aminoC1-6alkyl, Ar3thioC1-6alkyl, Het1thioC1-6alkyl, Ar3sulfonylC1-6alkyl, Het1sulfonylC1-6alkyl, Ar3aminocarbonyl, Het1aminocarbonyl, Ar3(CH2)namino-carbonyl, Het1(CH2)naminocarbonyl, Ar3carbonylamino, Het1carbonylamino, Ar3(CH2)ncarbonylamino, Het1(CH2)ncarbonylamino, and the other one of R2a and R2b is hydrogen; in case R2a is hydrogen, then R3 is hydrogen; in case R2b is hydrogen, the R3 is hydrogen or C1-6alkyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.

    摘要翻译: 本发明涉及对呼吸道合胞病毒复制具有抑制活性的5-或6-取代苯并咪唑衍生物,其具有前药,N-氧化物,加成盐,季胺,金属络合物或其立体化学异构形式,其中Q 是Ar 2,R 6,被R 6取代的吡咯烷基,被R 6取代的哌啶基或被R 6取代的高哌啶基,G是直接键或任意取代的C 1-10烷二基; R1是Ar1或单环或双环杂环; R2a和R2b之一是氰基C 1-6烷基,氰基C 2-6烯基,Ar 3 C 1-6烷基,Het 1 C 1-6烷基,N(R 8 a R 8 b)C 1-6烷基,Ar 3 C 2-6烯基,Het 1 C 2-6烯基,Ar 3氨基C 1-6烷基,Het 1氨基C 1-6烷基,Ar 3硫代C 1-6烷基, (CH 2)n氨基 - 羰基,Het 1(CH 2)n氨基羰基,Ar 3羰基氨基,Het 1羰基氨基,Ar 3(CH 2)n - 羰基氨基,Het 1(CH 2)n - 羰基氨基,和另一个(CH 2)n C 1 -C 6烷基, R2a和R2b是氢; 在R2a为氢的情况下,R3为氢; 在R2b为氢的情况下,R3为氢或C1-6烷基。 它还涉及它们的制备方法和包含它们的组合物,以及它们作为药物的用途。

    2-SUBSTITUTED BENZIMIDAZOLES
    9.
    发明申请

    公开(公告)号:US20100092426A1

    公开(公告)日:2010-04-15

    申请号:US11993136

    申请日:2006-06-20

    CPC分类号: C07D401/06 C07D235/30

    摘要: Inhibitors of RSV replication of formula (I) the addition salts and stereochemically isomeric forms thereof, wherein Q is hydrogen, C1-6alkyl optionally substituted with a heterocycle or Q is C1-6alkyl substituted with both —OR4 and a heterocycle; wherein said heterocycle is oxazolidine, thiazolidine, 1-oxo-thiazolidine, 1,1-dioxothiazolidine, morpholinyl, thiomorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxothiomorpholinyl, hexahydrooxazepine, hexahydro-thiazepine, 1-oxo-hexahydrothiazepine, 1,1-dioxo-hexahydrothiazepine, pyrrolidine, piperidine, homopiperidine, piperazine; which heterocyle may be substituted with 1-2 substituents; each Alk is C1-6alkanediyl; R1 is Ar2 or optionally substituted piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, tetrahydro-furanyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazolyl, isoxazolyl, oxadiazolyl, quinolinyl, quinoxalinyl, benzofuranyl, benzothienyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, pyridopyridyl, naphthiridinyl, 1H-imidazo[4,5-b]pyridinyl, 3H-imidazo[4,5-b]pyridinyl, imidazo[1,2-a]pyridinyl or 2,3-dihydro-1,4-dioxino[2,3-b]pyridyl; R3 is hydroxyC1-6alkyl, C1-6alkoxyC1-6alkyl, cyanoC1-6alkyl, aminocarbonyl-C1-6-alkyl, mono- or di(C1-6alkyl)aminocarbonyl-C1-6-alkyl, carboxyl-C1-6-alkyl, C1-6alkoxycarbonyl-C1-6alkyl; R2 is hydrogen or C1-6alkyl; R3 and R4 are hydrogen, C1-6alkyl, Ar2, Ar2C1-6alkyl, C1-6alkylcarbonyl, Ar2carbonyl, Ar2C1-6alkylcarbonyl, C1-6alkylsulfonyl, aminosulfonyl, Ar1sulfonyl, Ar1C1-6alkylsulfonyl, C1-6alkyloxyC1-6alkyl, aminoC1-6alkyl, mono- or di(C1-6alkyl)-aminoC1-6alkyl, hydroxyC1-6alkyl, aminocarbonylC1-6alkyl, C1-4alkyloxycarbonyl-C1-6alkyl, hydroxycarbonylC1-6alkyl, aminosulfonylC1-6alkyl, Het, Het-C1-6alkyl, Het-carbonyl, Het-sulfonyl, HetC1-6alkylsulfonyl, Het-C1-6alkylcarbonyl; Het is an optionally substituted heterocycle; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I).

    Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives
    10.
    发明授权
    Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives 有权
    法呢基蛋白转移酶抑制(咪唑-5-基)甲基-2-喹啉酮衍生物

    公开(公告)号:US06420387B1

    公开(公告)日:2002-07-16

    申请号:US09689211

    申请日:2000-10-12

    IPC分类号: A61K31445

    摘要: This invention comprises the novel compounds of formula (I) wherein the dotted line represents an optional bond; X is oxygen or sulfur; R1 is hydrogen, C1-12alkyl, Ar1, Ar2C1-6alkyl, quinolinylC1-6alkyl, pyridylC1-6alkyl, hydroxyC1-6alkyl, C1-6alkyloxyC1-6alkyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, aminoC1-6alkyl, or a radical of formula —Alk1—C(═O)—R9, —Alk1—S(O)—R9 or —Alk1—S(O)2—R9; R2, R3 and R16 each independently are hydrogen, hydroxy, halo, cyano, C1-6alkyl, C1-6alkyloxy, hydroxyC1-6akyloxy, C1-6alkyloxyC1-6alkyloxy, aminoC1-6alkyloxy, mono- or di(C1-6alkyl)aminoC1-6alkyloxy, Ar1, Ar2C1-6alkyl, Ar2oxy, Ar2C1-6alkyloxy, hydroxycarbonyl, C1-6alkyloxycarbonyl, trihalomethyl, trihalomethoxy, C2-6alkenyl; R4 and R5 each independently are hydrogen, halo, Ar1, C1-6alkyl, hydroxyC1-6alkyl, C1-6alkyloxyC1-6alkyl, C1-6alkyloxy, C1-6alkylthio, amino, hydroxycarbonyl, C1-6alkyloxycarbonyl, C1-6alkylS(O)C1-6alkyl or C1-6alkylS(O)2C1-6alkyl; R6 and R7 each independently are hydrogen, halo, cyano, C1-6alkyl, 4,4-dimethyl-oxazolyl, C1-6alkyloxy or Ar2oxy; R8 is hydrogen, C1-6alkyl, cyano, hydroxycarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonylC1-6alkyl; cyanoC1-6alkyl, C1-6alkyloxycarbonylC1-6alkyl, carboxyC1-6alkyl, hydroxyC1-6alkyl, aminoC1-6alkyl, mono- or di(C1-6alkyl)aminoC1-6alkyl, imidazolyl, haloC1-6alkyl, C1-6alkyloxyC1-6alkyl, aminocarbonylC1-6alkyl, or a radical of formula —O—R10, —SR10, —N—R11R12; R17 is hydrogen, halo, cyano, C1-6alkyl, C1-6alkyloxycarbonyl, Ar1; R18 is hydrogen, C1-6alkyl, C1-6alkyloxy or halo; R19 is hydrogen or C1-6alkyl; having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.

    摘要翻译: 本发明包括式(I)的新化合物,其中虚线表示任选的键; X是氧或硫; R1是氢,C1-12烷基,Ar1,Ar2C1-6烷基,喹啉基C 1-6烷基,吡啶基C 1-6烷基,羟基C 1-6烷基,C 1-6烷氧基C 1-6烷基,一或二(C 1-6烷基)氨基C 1-6烷基,氨基C 1-6烷基或 式-Alk1-C(= O)-R9,-Alk1-S(O)-R9或-Alk1-S(O)2-R9的基团; R 2,R 3和R 16各自独立地是氢,羟基,卤素,氰基,C 1-6烷基,C 1-6烷氧基,羟基C 1-6烷氧基,C 1-6烷氧基C 1-6烷氧基,氨基C 1-6烷氧基,一或二(C 1-6烷基)氨基C 1-6烷氧基 Ar 1,Ar 2 C 1-6烷基,Ar 2氧基,Ar 2 C 1-6烷氧基,羟基羰基,C 1-6烷氧基羰基,三卤代甲基,三卤代甲氧基,C 2-6烯基; R 4和R 5各自独立地是氢,卤素,Ar 1,C 1-6烷基,羟基C 1-6烷基,C 1-6烷氧基C 1-6烷基,C 1-6烷氧基,C 1-6烷硫基,氨基,羟基羰基,C 1-6烷氧基羰基,C 1-6烷基S(O) C 1-6烷基或C 1-6烷基S(O)2 C 1-6烷基; R 6和R 7各自独立地为氢,卤素,氰基,C 1-6烷基,4,4-二甲基 - 恶唑基,C 1-6烷氧基或Ar 2氧基; R 8是氢,C 1-6烷基,氰基,羟基羰基,C 1-6烷氧基羰基,C 1-6烷基羰基C 1-6